IGFBP-3 activates TGF-beta receptors and directly inhibits growth in human intestinal smooth muscle cells.
about
Insulin-like growth factors in the gastrointestinal tract and liverRegulation of retinal endothelial cell apoptosis through activation of the IGFBP-3 receptor.Mechanisms that mediate the development of fibrosis in patients with Crohn's disease.Insulin-like growth factor-binding protein-5 stimulates growth of human intestinal muscle cells by activation of G{alpha}i3.Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis.Gene expression profiling of early hepatic stellate cell activation reveals a role for Igfbp3 in cell migration.Insulin-like growth factor binding protein-3 is required for the regulation of rat oval cell proliferation and differentiation in the 2AAF/PHX model.Insulin-like growth factor binding protein-3 inhibits cell adhesion via suppression of integrin β4 expression.Expression of albumin, IGF-1, IGFBP-3 in tumor tissues and adjacent non-tumor tissues of hepatocellular carcinoma patients with cirrhosisPancreatic cancer cell-derived IGFBP-3 contributes to muscle wastingEndogenous IGFBP-3 regulates excess collagen expression in intestinal smooth muscle cells of Crohn's disease strictures.Insulin-like growth factor binding protein-3 (IGFBP-3): Novel ligands mediate unexpected functions.Increased activation of latent TGF-β1 by αVβ3 in human Crohn's disease and fibrosis in TNBS colitis can be prevented by cilengitide.Potential applications for cell regulatory factors in liver progenitor cell therapy.Signalling pathways of insulin-like growth factors (IGFs) and IGF binding protein-3.Insulin-like growth factor binding proteins-3 and -5: central mediators of fibrosis and promising new therapeutic targets.Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787/ZK22258Endogenous IGF-I protects human intestinal smooth muscle cells from apoptosis by regulation of GSK-3 beta activity.Colostrum Supplementation Restores Insulin-like Growth Factor -1 Levels and Alters Muscle Morphology Following Massive Small Bowel Resection
P2860
Q26998926-402F9546-D693-45BC-8E4A-5955A6EF37CCQ33632210-1BE6866B-5B15-4B99-8486-32F6D832370AQ33754181-90740DD6-6DB0-428E-964A-33A31D50EABDQ33771765-061BE229-B0F7-43A0-A118-F4C839512901Q34382756-A4568D2B-D5A1-4AD5-801F-FCB280603C75Q35073234-A2A8A5A8-FDDF-4FF2-A098-8DBBC667A686Q35165646-FCA5B1E3-1B92-4A59-AC90-066ABBD2D0E6Q36020955-16FD6D43-5415-4BFE-9353-51B59952A8B3Q36190553-C47ED06C-8E16-42F7-BBCA-0B92377D0E44Q36686835-73BA6FCF-FA49-4E54-9DE1-667B6407CADDQ36892466-C18C1AF6-47D9-40FF-B9E9-724D8887726DQ37004744-9CA8A247-C0F5-4E27-8247-B503B8E06D2EQ37469875-8DCF6C8B-2770-402B-A8D0-DA8168B3AFE0Q37790160-2A3D001C-950F-4256-B050-0AD3F572F3C9Q37927102-4C748177-5E7E-44A8-8DF6-CCD0F3D9CB37Q38026844-F7C79581-7AC1-4E23-84B6-ADA87771139AQ41425182-45E9E86C-05CC-4C67-9A52-D5D287FC8BACQ44904081-DE80442E-2370-4617-B91B-C2323454AB6FQ58433721-A9A9F8B7-E49B-4938-90FA-E861C7268E17
P2860
IGFBP-3 activates TGF-beta receptors and directly inhibits growth in human intestinal smooth muscle cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
IGFBP-3 activates TGF-beta rec ...... ntestinal smooth muscle cells.
@en
IGFBP-3 activates TGF-beta rec ...... ntestinal smooth muscle cells.
@nl
type
label
IGFBP-3 activates TGF-beta rec ...... ntestinal smooth muscle cells.
@en
IGFBP-3 activates TGF-beta rec ...... ntestinal smooth muscle cells.
@nl
prefLabel
IGFBP-3 activates TGF-beta rec ...... ntestinal smooth muscle cells.
@en
IGFBP-3 activates TGF-beta rec ...... ntestinal smooth muscle cells.
@nl
P2093
P2860
P356
P1476
IGFBP-3 activates TGF-beta rec ...... ntestinal smooth muscle cells.
@en
P2093
Jennifer G Bowers
John F Kuemmerle
Karnam S Murthy
P2860
P304
P356
10.1152/AJPGI.00009.2004
P577
2004-06-03T00:00:00Z